| Performance of pneumonia severity index and CURB-65 in predicting 30-day mortality in patients with COVID-19 C Satici, MA Demirkol, ES Altunok, B Gursoy, M Alkan, S Kamat, ... International Journal of Infectious Diseases 98, 84-89, 2020 | 186 | 2020 |
| Management of major organ involvement of Behçet’s syndrome: a systematic review for update of the EULAR recommendations Y Ozguler, P Leccese, R Christensen, SN Esatoglu, D Bang, B Bodaghi, ... Rheumatology 57 (12), 2200-2212, 2018 | 114 | 2018 |
| Characteristics, treatment, and long-term outcome of gastrointestinal involvement in Behcet's syndrome: a strobe-compliant observational study from a dedicated … I Hatemi, SN Esatoglu, G Hatemi, Y Erzin, H Yazici, AF Celik Medicine 95 (16), e3348, 2016 | 93 | 2016 |
| Management of skin, mucosa and joint involvement of Behcet’s syndrome: a systematic review for update of the EULAR recommendations for the management of Behcet’s syndrome P Leccese, Y Ozguler, R Christensen, SN Esatoglu, D Bang, B Bodaghi, ... Seminars in Arthritis and Rheumatism 48 (4), 752-762, 2019 | 79 | 2019 |
| Behçet’s syndrome: providing integrated care SN Esatoglu, Z Kutlubay, D Ucar, I Hatemi, U Uygunoglu, A Siva, ... Journal of multidisciplinary healthcare, 309-319, 2017 | 66 | 2017 |
| Bone marrow transplantation for Behçet’s disease: a case report and systematic review of the literature T Soysal, A Salihoğlu, SN Esatoğlu, E Gültürk, AE Eşkazan, G Hatemi, ... Rheumatology 53 (6), 1136-1141, 2014 | 59 | 2014 |
| Update on the treatment of Behçet’s syndrome SN Esatoglu, G Hatemi Internal and Emergency Medicine 14 (5), 661-675, 2019 | 56 | 2019 |
| A reappraisal of the association between Behçet’s disease, myelodysplastic syndrome and the presence of trisomy 8: a systematic literature review SN Esatoglu, G Hatemi, A Salihoglu, I Hatemi, T Soysal, AF Celik Clin Exp Rheumatol 33 (6 Suppl 94), S145-S151, 2015 | 56 | 2015 |
| Infliximab for uveitis of Behçet’s syndrome: a trend for earlier initiation G Guzelant, D Ucar, SN Esatoglu, G Hatemi, Y Ozyazgan, S Yurdakul, ... Clin Exp Rheumatol 35 (Suppl 108), 86-9, 2017 | 35 | 2017 |
| Secukinumab induced Behçet’s syndrome: a report of two cases E Dincses, B Yurttas, SN Esatoglu, M Melikoglu, V Hamuryudan, E Seyahi Oxford Medical Case Reports 2019 (5), omz041, 2019 | 34 | 2019 |
| Developing a core set of outcome measures for Behçet disease: report from OMERACT 2016 G Hatemi, A Meara, Y Ozguler, H Direskeneli, A Mahr, E Easley, ... The Journal of rheumatology 44 (11), 1750-1753, 2017 | 32 | 2017 |
| Long-term follow-up of secondary amyloidosis patients treated with tumor necrosis factor inhibitor therapy: A STROBE-compliant observational study SN Esatoglu, G Hatemi, S Ugurlu, A Gokturk, K Tascilar, H Ozdogan Medicine 96 (34), e7859, 2017 | 29 | 2017 |
| COVID-19 among patients with inflammatory rheumatic diseases SN Esatoglu, K Tascilar, H Babaoğlu, C Bes, B Yurttas, S Akar, ... Frontiers in Immunology 12, 651715, 2021 | 26 | 2021 |
| How to treat myelodysplastic syndrome with clinical features resembling Behçet syndrome: a case-based systematic review U Yilmaz, MC Ar, SN Esatoglu, I Bavunoglu, YZ Erzin, AI Hatemi, ... Annals of hematology 99, 1193-1203, 2020 | 26 | 2020 |
| Long term follow-up of Behçet’s syndrome patients treated with cyclophosphamide M Gurcan, SN Esatoglu, V Hamuryudan, D Saygin, S Ugurlu, E Seyahi, ... Rheumatology 59 (9), 2264-2271, 2020 | 24 | 2020 |
| Meeting Report Highlights of the 17th International Conference on Behçet’s syndrome SN Esatoglu, G Hatemi, P Leccese, I Olivieri Clin Exp Rheumatol 34 (102), S3-S9, 2016 | 24 | 2016 |
| Comparison of demographic and clinical characteristics of hospitalized COVID‐19 patients with severe/critical illness in the first wave versus the second wave E Sargin Altunok, C Satici, V Dinc, S Kamat, M Alkan, MA Demirkol, ... Journal of Medical Virology 94 (1), 291-297, 2022 | 23 | 2022 |
| Bronchial artery enlargement may be the cause of recurrent haemoptysis in Behcet’s syndrome patients with pulmonary artery involvement during follow-up SN Esatoglu, E Seyahi, S Ugurlu, F Gulsen, C Akman, M Cantasdemir, ... Clin Exp Rheumatol 34 (6 Suppl 102), 92-96, 2016 | 23 | 2016 |
| Takayasu arteritis SN Esatoglu, G Hatemi Current Opinion in Rheumatology 34 (1), 18-24, 2022 | 22 | 2022 |
| Takayasu s arteritis: associated inflammatory diseases V Hamuryudan, H Yazici, E Seyahi Clin Exp Rheumatol 38 (124), S61-S8, 2020 | 22 | 2020 |
